Sexual dysfunction and infertility as late effects of cancer treatment

European Journal of Cancer, Supplement

Volumn 12, Issue 1, 2014, Pages 41-53

  Schover, Leslie R ^a   van der Kaaij, Marleen ^b   van Dorst, Eleonora ^c   Creutzberg, Carien ^d   Huyghe, Eric ^e   Kiserud, Cecilie E ^f  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CHU RANGUEIL   (France)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Fertility preservation; Late effects; Oncofertility; Oncology; Sexual dysfunction; Sexuality

Indexed keywords

ANTINEOPLASTIC AGENT;

ANUS CANCER; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; DECISION SUPPORT SYSTEM; ERECTILE DYSFUNCTION; FEMALE INFERTILITY; FEMALE SEXUAL DYSFUNCTION; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MALE INFERTILITY; MALE SEXUAL DYSFUNCTION; MULTIMODALITY CANCER THERAPY; NONHUMAN; OVARIAN RESERVE; PARENTHOOD; PATIENT COUNSELING; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SEXUALITY; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 84904741886     PISSN: 13596349     EISSN: 18781217     Source Type: Journal    
DOI: 10.1016/j.ejcsup.2014.03.004     Document Type: Article

References (191)

1. American Cancer Society Cancer treatment and survivorship facts & figures 2012-2013 2012, American Cancer Society, Atlanta.
2. Sadovsky R., Basson R., Krychman M., Morales A.M., Schover L., Wang R., et al. Cancer and sexual problems. J Sex Med 2010, 7(1 Pt 2):349-373.
3. Rowland J.H., Kent E.E., Forsythe L.P., Håvard Loge J., Hjorth L., Glaser A., et al. Cancer survivorship research in Europe and the United States: where have we been, where are we going, and what can we learn from each other?. Cancer 2013, Suppl. 119:2094-2108.
4. Hall A.E., Boyes A.W., Bowman J., Walsh R.A., James E.L., Girgis A. Young adult cancer survivors' psychosocial well-being: a cross-sectional study assessing quality of life, unmet needs, and health behaviors. Support Care Cancer 2012, 20:1333-1341.
5. Li W.W., Lam W.W., Au A.H., Ye M., Law W.L., Poon J., et al. Interpreting differences in patterns of supportive care needs between patients with breast cancer and patients with colorectal cancer. Psychooncology 2013, 22:792-798.
6. McCallum M., Lefebvre M., Jolicoeur L., Maheu C., Lebel S. Sexual health and gynecological cancer: conceptualizing patient needs and overcoming barriers to seeking and accessing services. J Psychosom Obstet Gynaecol 2012, 33:135-142.
7. Knight S.J., Latini D.M. Sexual side effects and prostate cancer treatment decisions: patient information needs and preferences. Cancer J 2009, 15:41-44.
8. Reese J.B., Shelby R.A., Abernethy A.P. Sexual concerns in lung cancer patients: an examination of predictors and moderating effects of age and gender. Support Care Cancer 2011, 19:161-165.
9. Steinsvik E.A., Axcrona K., Dahl A.A., Eri L.M., Stensvold A., Fosså S.D. Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother. BJU Int 2012, 109:1366-1374.
10. van Londen GJ, Beckjord EB, Dew MA, Cooper KL, Davidson NE, Bovbjerg DH et al. Associations between adjuvant endocrine therapy and onset of physical and emotional concerns among breast cancer survivors. Support Care Cancer 2013, November 24 [Epublication ahead of print].
11. Milbury K., Cohen L., Jenkins R., Skibber J.M., Schover L.R. The association between psychosocial and medical factors with long-term sexual dysfunction after treatment for colorectal cancer. Support Care Cancer 2013, 21:793-802.
12. Puts M.T., Papoutsis A., Springall E., Tourangeau A.E. A systematic review of unmet needs of newly diagnosed older cancer patients undergoing active cancer treatment. Support Care Cancer 2012, 20:1377-1394.
13. Baumgart J., Nilsson K., Evers A.S., Kallak T.K., Poromaa I.S. Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause 2013, 20:162-168.
14. Den Oudsten B.L., Traa M.J., Thong M.S., Martijn H., De Hingh I.H., Bosscha K., et al. Higher prevalence of sexual dysfunction in colon and rectal cancer survivors compared with the normative population: a population-based study. Eur J Cancer 2012, 48:3161-3170.
15. Froeding LP, Ottosen C, Rung-Hansen H, Svane D, Mosgaard BJ, Jensen PT. Sexual functioning and vaginal changes after radical vaginal trachelectomy in early stage cervical cancer patients: a longitudinal study. J Sex Med 2013, November 29 [Epublication ahead of print].
16. Hedgepeth R.C., Gilbert S.M., He C., Lee C.T., Wood D.P. Body image and bladder cancer specific quality of life in patients with ileal conduit and neobladder urinary diversions. Urology 2010, 76:671-675.
17. Kyrdalen A.E., Dahl A.A., Hernes E., Småstuen M.C., Fosså S.D. A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer. BJU Int 2013, 111:221-232.
18. Le Borgne G., Mercier M., Woronoff A.S., Guizard A.V., Abeilard E., Caravati-Jouvenceaux A., et al. Quality of life in long-term cervical cancer survivors: a population-based study. Gynecol Oncol 2013, 129:222-228.
19. Lind H., Waldenström A.-C., Dunberger G., Al-Abany M., Alevronta E., Johansson K.A., Olsson C., et al. Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study. Br J Cancer 2011, 104:737-745. PMCID: PMC3171018.
20. Resnick M.J., Koyama T., Fan K.H., Albertsen P.C., Goodman M., Hamilton A.S., et al. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med 2013, 368:436-445.
21. Lindau S.T., Surawska H., Paice J., Baron S.R. Communication about sexuality and intimacy in couples affected by lung cancer and their clinical-care providers. Psychooncology 2011, 20:179-185. PMCID: PMC3319754.
22. Thygesen K.H., Schjødt I., Jarden M. The impact of hematopoietic stem cell transplantation on sexuality: a systematic review of the literature. Bone Marrow Transplant 2012, 47:716-724.
23. Henry M, Habib LA, Morrison M, Yang JW, Li XJ, Lin S et al. Head and neck cancer patients want us to support them psychologically in the posttreatment period: Survey results. Palliat Support Care 2013, October 24 [Epublication ahead of print].
24. Bober S.L., Zhou E.S., Chen B., Manley P.E., Kenney L.B., Recklitis C.J. Sexual function in childhood cancer survivors: a report from Project REACH. J Sex Med 2013, 10:2084-2093.
25. Zebrack B.J., Foley S., Wittmann D., Leonard M. Sexual functioning in young adult survivors of childhood cancer. Psychooncology 2010, 198:814-822.
26. Strasser F., Palmer J.L., Schover L.R., Yusuf S.W., Pisters K., Vassilopoulou-Sellin R., et al. The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study. Cancer 2006, 107:2949-2957.
27. Dunberger G., Lind H., Steineck G., Waldenström A.C., Nyberg T., Al-Abany M., et al. Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls. Eur J Cancer 2010, 46:606-615. PMID: 19926277.
28. Tekkis P.P., Cornish J.A., Remzi F.H., Tilney H.S., Strong S.A., Church J.M., et al. Measuring sexual and urinary outcomes in women after rectal cancer excision. Dis Colon Rectum 2009, 52:46-54. PMID: 19273955.
29. Frey AU, Sønksen J, Fode M. Neglected side effects after radical prostatectomy: a systematic review. J Sex Med 2013, November 25 [Epublication ahead of print].
30. Barnas J.L., Pierpaoli S., Ladd P., Valenzuela R., Aviv N., Parker M., et al. The prevalence and nature of orgasmic dysfunction after radical prostatectomy. BJU Int 2004, 94:603-605.
31. Dalkin B.L., Christopher B.A. Potent men undergoing radical prostatectomy: a prospective study measuring sexual health outcomes and the impact of erectile dysfunction treatments. Urol Oncol 2008, 26:281-285. http://www.sciencedirect.com/science/article/pii/S1078143907000671#.
32. Kimura M., Bañez L.L., Schroeck F.R., Gerber L., Qi J., Satoh T., et al. Factors predicting early and late phase decline of sexual health related quality of life following radical prostatectomy. J Sex Med 2011, 8:2935-2943.
33. Nelson C., Scardino P.T., Eastham J.A., Mulhall J.P. Back to baseline: erectile function recovery after radical prostatectomy from the patients' perspective. J Sex Med 2013, 6:1636-1643. PMID: 23551767.
34. Budäus L., Bolla M., Bossi A., Cozzarini C., Crook J., Widmark A., et al. Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature. Eur Urol 2012, 61:112-127. PMID: 22001105.
35. Lilleby W., Stensvold A., Dahl A.A. Intensity-modulated radiotherapy to the pelvis and androgen deprivation in men with locally advanced prostate cancer: a study of adverse effects and their relation to quality of life. Prostate 2013, 73:1038-1047. PMID:23532709.
36. Sheets N.C., Goldin G.H., Meyer A.M., Wu Y., Chang Y., Stürmer T., et al. Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA 2012, 18(307):1611-1620. PMID:23532709.
37. Bekelman J.E., Mitra N., Efstathiou J., Liao K., Sunderland R., Yeboa D.N., et al. Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys 2011, 81:e325-334. PMID: 21498008.
38. Whaley J.T., Levy L.B., Swanson D.A., Pugh T.J., Kudchadker R.J., Bruno T.L., et al. Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy. Int J Radiat Oncol Biol Phys 2012, 82:e765-771. PMID: 22300559.
39. Incrocci L., Jensen P.T. Pelvic radiotherapy and sexual function in men and women. J Sex Med 2013, 10(Suppl. 1):53-64. PMID: 23387912.
40. Johansson E., Steineck G., Holmberg L., Johansson J.E., Nyberg T., Ruutu M., SPCG-4 Investigators, et al. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol 2011, 12:891-899.
41. Taylor K.L., Luta G., Miller A.B., Church T.R., Kelly S.P., Muenz L.R., et al. Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial. J Clin Oncol 2012, 30:2768-2775.
42. Mohamed NE, Chaoprang Herrera P, Hudson S, Revenson TA, Lee CT, Quale DZ et al. Muscle invasive bladder cancer: examining survivors' burden and unmet needs. J Urol 2013, July 30 [Epublication ahead of print] PMID: 23911603.
43. Traa MJ, De Vries J, Roukema JA, Rutten HJ, Den Oudsten BL. The sexual health care needs after colorectal cancer: the view of patients, partners, and health care professionals. Support Care Cancer 2013, November 18 [Epublication ahead of print].
44. Bentzen A.G., Balteskard L., Wanderås E.H., Frykholm G., Wilsgaard T., Dahl O., et al. Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors. Acta Oncol 2013, 52:736-744.
45. Kiserud C.E., Schover L.R., Dahl A.A., Fosså A., Bjøro T., Loge J.H., et al. Do male lymphoma survivors have impaired sexual function?. J Clin Oncol 2009, 27:6019-6026.
46. Aksoy S., Harputluoglu H., Kilickap S., et al. Erectile dysfunction in successfully treated lymphoma. Support Care Cancer 2008, 16:291-297.
47. Yau I., Vuong T., Garant A., Ducruet T., Doran P., Faria S., et al. Risk of hypogonadism from scatter radiation during pelvic radiation in male patients with rectal cancer. Int J Radiat Oncol Biol Phys 2009, 74:1481-1486. PMID: 19147304.
48. Herman J.M., Narang A.K., Griffith K.A., Zalupski M.M., Reese J.B., Gearhart S.L., et al. The quality-of-life effects of neoadjuvant chemoradiation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2013, 85:e15-19. PMCID: PMC3578309.
49. Tal R., Stember D.S., Logmanieh N., Narus J., Mulhall J.P. Erectile dysfunction in men treated for testicular cancer. BJU Int 2013, [Epub ahead of print]. 10.1111/bju.12331.
50. Willemse P.M., Burggraaf J., Hamdy N.A., Weijl N.I., Vossen C.Y., van Wulften L., et al. Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors. Br J Cancer 2013, 109:60-67.
51. Recklitis C.J. Sanchez Varela V, Ng A, Mauch P, Bober S. Sexual functioning in long-term survivors of Hodgkin's lymphoma. Psychooncology 2010, 19:1229-1233.
52. Mulhall J.P., Bivalacqua T.J., Becher E.F. Standard operating procedure for the preservation of erectile function outcomes after radical prostatectomy. J Sex Med 2013, 10:195-203.
53. Schover L.R. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol 2008, 26:753-758. PMID: 18258983.
54. Finch A., Evans G., Narod S.A. BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations. Womens Health (Lond Engl). 2012, 8:543-555. http://www.futuremedicine.com/doi/abs/10.2217/whe.12.41?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dwww.ncbi.nlm.nih.gov&.
55. Bober S.L., Giobbie-Hurder A., Emmons K.M., Winer E., Partridge A. Psychosexual functioning and body image following a diagnosis of ductal carcinoma in situ. J Sex Med 2013, 10:370-377.
56. Ochsenkühn R., Hermelink K., Clayton A.H., von S.V., Gallwas J., Ditsch N. Menopausal status in breast cancer patients with past chemotherapy determines long-term hypoactive sexual desire disorder. J Sex Med 2011, 8:1486-1494.
57. Provencher S., Oehler C., Lavertu S., Jolicoeur M., Fortin B., Donath D. Quality of life and tumor control after short split-course chemoradiation for anal canal carcinoma. Radiation Oncol 2010, 5:41-49. PMCID: PMC2883545.
58. Hirsch P., Leclerc M., Rybojad M., Petropoulou A.D., Robin M., Ribaud P., et al. Female genital chronic graft-versus-host disease: importance of early diagnosis to avoid severe complications. Transplantation 2012, 93:1265-1269.
59. Carr S. Communication about sexuality and cancer. Cancer and sexual health 2011, 307-316. Humana Press, New York. J.P. Mulhall (Ed.).
60. Fitch M.I., Beaudoin G., Johnson B. Challenges having conversations about sexuality in ambulatory settings: part II-health care provider perspectives. Can Oncol Nurs J 2013, 23:182-196.
61. Hordern A.J., Street A.F. Constructions of sexuality and intimacy after cancer: patient and health professional perspectives. Soc Sci Med 2007, 64:1704-1718.
62. Flynn K.E., Reese J.B., Jeffery D.D., Abernethy A.P., Lin L., Shelby R.A., et al. Patient experiences with communication about sex during and after treatment for cancer. Psychooncology 2012, 21:594-601. PMCID: PMC3149787.
63. Ussher J.M., Perz J., Gilbert E., Wong W.K., Mason C., Hobbs K., et al. Talking about sex after cancer: a discourse analytic study of health care professional accounts of sexual communication with patients. Psychol Health 2013, 28:1370-1390.
64. Julien J.O., Thom B., Kling N.E. Identification of barriers to sexual health assessment in oncology nursing practice. Oncol Nursing Forum 2010, 37:E186-190.
65. Takahashi M., Kai I., Hisata M., Higashi Y. Attitudes and practices of breast cancer consultations regarding sexual issues: a nationwide survey of Japanese surgeons. J Clin Oncol 2006, 24:5763-5768.
66. Platano G., Margraf J., Alder J., Bitzer J. Psychosocial factors and therapeutic approaches in the context of sexual history taking in men: a study conducted among Swiss general practitioners and urologists. J Sex Med 2008, 5:2533-2556.
67. Parish S., Clayton A.H. Sexual medicine education: review and commentary. J Sex Med 2007, 4:259-268.
68. Zeng Y.C., Li Q., Wang N., Ching S.S., Loke A.Y. Chinese nurses' attitudes and beliefs toward sexuality care in cancer patients. Cancer Nurs 2011, 34:E14-20.
69. Flynn K.E., Jeffery D.D., Keefe F.J., Porter L.S., Shelby R.A., Fawzy M.R., et al. Sexual functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS®). Psychooncology 2011, 20:378-386.
70. de Vocht H., Hordern A., Notter J., Van de Wiel H. Stepped skills: A team approach towards communication about sexuality and intimacy in cancer and palliative care. Austral Med J 2011, 4:610-619.
71. Dyer K, das Nair R. Why don't healthcare professionals talk about sex? A systematic review of recent qualitative studies conducted in the United Kingdom. J Sex Med 2012, July 30 [Epublication ahead of print].
72. Forbat L., White I., Marshall-Lucette S., Kelly D. Discussing the sexual consequences of treatment in radiotherapy and urology consultations with couples affected by prostate cancer. BJU Int 2012, 109:98-103.
73. Reese J.B., Keefe F.J., Somers T.J., Abernethy A.P. Coping with sexual concerns after cancer: the use of flexible coping. Support Care Cancer 2010, 18:785-800.
74. Thompson K., Dyson G., Holland L., Joubert L. An exploratory study of oncology specialists' understanding of the preferences of young people living with cancer. Soc Work in Health Care 2013, 52:166-190.
75. White I.D., Faithfull S., Allan H. The re-construction of women's sexual lives after pelvic radiotherapy: a critique of social constructionist and biomedical perspectives on the study of female sexuality after cancer treatment. Soc Sci Med 2013, 76:186-196.
76. Nicolai M.P., Both S., Liem S.S., Pelger R.C., Putter H., Schalij M.J., et al. Discussing sexual function in the cardiology practice. Clin Res Cardiol 2013, 102:329-336.
77. Lamont J. Female sexual health consensus clinical guidelines. J Obstet Gynaecol Can 2012, 34:769-775.
78. Sobecki J.N., Curlin F.A., Rasinski K.A., Lindau S.T. What we don't talk about when we don't talk about sex: results of a national survey of U.S. obstetrician/gynecologists. J Sex Med 2012, 9(5):1285-1294.
79. Abdolrasulnia M., Shewchuk R.M., Roepke N., Granstaff U.S., Dean J., Foster J.A., Goldstein A.T., et al. Management of female sexual problems: perceived barriers, practice patterns, and confidence among primary care physicians and gynecologists. J Sex Med 2010, 7:2499-2508.
80. Jiwa M., O'Shea C., Merriman G., Halkett G., Spilsbury K. Psychosexual problems in general practice: measuring consultation competence using two different measures. Qual Prim Care 2010, 18:243-260.
81. Miller S.A., Byers E.S. Practicing psychologists' sexual intervention self-efficacy and willingness to treat sexual issues. Arch Sex Behav 2012, 41:1041-1050.
82. Ghanem H., Shamloul R. An evidence-based perspective to commonly performed erectile dysfunction investigations. J Sex Med 2008, 5:1582-1589.
83. Latif E.Z., Diamond M.P. Arriving at the diagnosis of female sexual dysfunction. Fertil Steril 2013, 100:898-904.
84. Althof S.E., Parish S.J. Clinical interviewing techniques and sexuality questionnaires for male and female cancer patients. J Sex Med 2013, 10(Suppl 1):35-42.
85. Chipman J.J., Sanda M.G., Dunn R.L., Wei J.T., Litwin M.S., Crociani C.M., PROST-QA Consortium, et al. Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice. J Urol 2014, 191:638-645.
86. Baser R.E., Li Y., Carter J. Psychometric validation of the female sexual function index (FSFI) in cancer survivors. Cancer 2012, 118:4606-4618.
87. Flynn K.E., Lin L., Cyranowski J.M., Reeve B.B., Reese J.B., Jeffery D.D., et al. Development of the NIH PROMIS® sexual function and satisfaction measures in patients with cancer. J Sex Med 2013, 10(Suppl. 1):43-52.
88. Hill E.K., Sandbo S., Abramsohn E., Makelarski J., Wroblewski K., Wenrich E.R., et al. Assessing gynecologic and breast cancer survivors' sexual health care needs. Cancer 2011, 117:2643-2651. PMCID: PMC3084902.
89. Huyghe E., Sui D., Odensky E., Schover L.R. Needs assessment survey to justify establishing a reproductive health clinic at a comprehensive cancer center. J Sex Med 2009, 6:149-163.
90. Schover L.R., Fouladi R.T., Warneke C.L., Neese L., Klein E.A., Zippe C., et al. The use of treatments for erectile dysfunction among survivors of prostate carcinoma. Cancer 2002, 95:2397-2407.
91. Prasad M.M., Prasad S.M., Hevelone N.D., et al. Utilization of pharmacotherapy for erectile dysfunction following treatment for prostate cancer. J Sex Med 2010, 7:1062-1073.
92. Holm L.V., Hansen D.G., Johansen C., Vedsted P., Larsen P.V., Kragstrup J., et al. Participation in cancer rehabilitation and unmet needs: a population-based cohort study. Support Care Cancer 2012, 20:2913-2924. PMCID: PMC3461205.
93. Park B.W., Hwang S.Y. Unmet needs and their relationship with quality of life among women with recurrent breast cancer. J Breast Cancer 2012, 15:454-461.
94. Adams E, Boulton MG, Horne A, Rose PW, Durrant L, Collingwood M et al. The effects of pelvic radiotherapy on cancer survivors: symptom profile, psychological morbidity and quality of life. Clin Oncol (R Coll Radiol) 2013, August 28 [Epublication ahead of print].
95. Hansen D.G., Larsen P.V., Holm L.V., Rottmann N., Bergholdt S.H., Søndergaard J. Association between unmet needs and quality of life of cancer patients: a population-based study. Acta Oncol 2013, 52:391-399.
96. Juraskova I., Bonner C., Bell M.L., Sharpe L., Robertson R., Butow P. Quantity vs. quality: an exploration of the predictors of posttreatment sexual adjustment for women affected by early stage cervical and endometrial cancer. J Sex Med 2012, 9:2952-2960.
97. Schover L.R., Canada A.L., Yuan Y., Sui D., Neese L., Jenkins R., et al. A randomized trial of internet-based versus traditional sexual counseling for couples after localized prostate cancer treatment. Cancer 2012, 118:500-509. http://onlinelibrary.wiley.com/doi/10.1002/cncr.26308/abstract;jsessionid=2900A2D001128F022CF37E12CA7DB985.f04t02.
98. Perz J., Ussher J.M., Gilbert E. Constructions of sex and intimacy after cancer: Q methodology study of people with cancer, their partners, and health professionals. BMC Cancer 2013, 13:270.
99. Beck A.M., Robinson J.W., Carlson L.E. Sexual values as the key to maintaining satisfying sex after prostate cancer treatment: the physical pleasure-relational intimacy model of sexual motivation. Arch Sex Behav 2013, 42:1637-1647.
100. Gilbert E., Ussher J.M., Perz J. Renegotiating sexuality and intimacy in the context of cancer: the experiences of carers. Arch Sex Behav 2010, 39:998-1009.
101. Carter J., Goldfrank D., Schover L.R. Simple strategies for vaginal health promotion in cancer survivors. J Sex Med 2011, 8:549-559.
102. Salonia A., Gallina A., Zanni G., Briganti A., Dehò F., Saccà A., et al. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008, 53:564-570. PMID: 17761385.
103. Bergman J., Gore J.L., Penson D.F., Kwan L., Litwin M.S. Erectile aid use by men treated for localized prostate cancer. J Urol 2009, 182:649-654. PMID: 19535108.
104. Stephenson R.A., Mori M., Hsieh Y.-C., Beer T.M., Stanford J.L., Gilliland F.D., et al. Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the surveillance, epidemiology, and end results prostate cancer outcomes study. J Urol 2005, 174:646-650. PMID: 16006930.
105. Mulhall J.P., Burnett A.L., Wang R., McVary K.T., Moul J.W., Bowden C.H., et al. A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy. J Urol 2013, 189:2229-2236. PMID: 23219537.
106. Carvalheira A.A., Pereira N.M., Maroco J., Forjaz V. Dropout in the treatment of erectile dysfunction with PDE5: a study on predictors and a qualitative analysis of reasons for discontinuation. J Sex Med 2012, 9:2361-2369. PMID 22616766.
107. Conaglen H.M., Conaglen J.V. Couples' reasons for adherence to, or discontinuation of, PDE type 5 inhibitors for men with erectile dysfunction at 12 to 24-month follow-up after a 6-month free trial. J Sex Med 2012, 9:857-865. PMID 22239731.
108. Derouet H., Caspari D., Rohde V., Rommel G., Ziegler M. Treatment of erectile dysfunction with external vacuum devices. Andrologia 1999, 31(Suppl 1):85-94. PMID: 10643525.
109. Dutta T.C., Eid J.F. Vacuum constriction devices for erectile dysfunction: a long-term, prospective study of patients with mild, moderate, and severe dysfunction. Urology 1999, 54:691-693. PMID: 10565753.
110. Tal R., Jacks L.M., Elkin E., Mulhall J.P. Penile implant utilization following treatment for prostate cancer: analysis of the SEER-Medicare database. J Sex Med 2011, 8:1797-1804. PMID: 21426495.
111. Brand A.H., Do V., Stenlake A. Can an educational intervention improve compliance with vaginal dilator use in patients treated with radiation for a gynecological malignancy?. Int J Gynecol Cancer 2012, 22:897-904.
112. Cullen K., Fergus K., Dasgupta T., Fitch M., Doyle C., Adams L. From, "sex toy" to intrusive imposition: a qualitative examination of women's experiences with vaginal dilator use following treatment for gynecological cancer. J Sex Med 2012, 9:1162-1173.
113. Kao A., Binik Y.M., Amsel R., Funaro D., Leroux N., Khalifé S. Biopsychosocial predictors of postmenopausal dyspareunia: the role of steroid hormones, vulvovaginal atrophy, cognitive-emotional factors, and dyadic adjustment. J Sex Med 2012, 9:2066-2076.
114. Stute P. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?. Arch Gynecol Obstet 2013, 288:1199-1201.
115. Coste I., Judlin P., Lepargneur J.P., Bou-Antoun S. Safety and efficacy of an intravaginal prebiotic gel in the prevention of recurrent bacterial vaginosis: a randomized double-blind study. Obstet Gynecol Int 2012, 2012:147867.
116. Cui Y, Zong H, Yan H, Li N, Zhang Y. The efficacy and safety of ospemifene in treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy: a systematic review and meta-analysis. J Sex Med 2013, November 20 [Epublication ahead of print].
117. Pinkerton JV, Stanczyk FZ. Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy. Menopause 2013, June 18 [Epublication ahead of print].
118. Schover L.R., Yuan Y., Fellman B.M., Odensky E., Lewis P.E., Martinetti P. Efficacy trial of an internet-based intervention for cancer-related female sexual dysfunction. J Natl Compr Canc Netw 2013, 11:1389-1397. PMCID: in process.
119. Giesler R.B., Given B., Given C.W., Rawl S., Monahan P., Burns D., et al. Improving the quality of life of patients with prostate carcinoma: a randomized trial testing the efficacy of a nurse-driven intervention. Cancer 2005, 104:752-762.
120. Weinrich S., Koch M., Champion V., Leykin Y., Thekdi S.M., Shumay D.M., et al. Internet interventions for improving psychological well-being in psycho-oncology: review and recommendations. Psychooncology 2012, 21:1016-1025. PMCID: PMC3181007.
121. Coker A.L., Follingstad D., Garcia L.S., Williams C.M., Crawford T.N., Bush H.M. Association of intimate partner violence and childhood sexual abuse with cancer-related well-being in women. J Womens Health (Larchmt) 2012, 21:1180-1188.
122. International Agency for Research on Cancer. GLOBOCAN 2012. Available from: ; 2012 [cited 1 February 2014]. http://globocan.iarc.fr.
123. Salonia A., Capogrosso P., Castiglione F., Russo A., Gallina A., Ferrari M., et al. Sperm banking is of key importance in patients with prostate cancer. Fertil Steril 2013, 100:367-372.
124. Bujan L., Walschaerts M., Moinard N., Hennebicq S., Saias J., Brugnon F., et al. Impact of chemotherapy and radiotherapy for testicular germ cell tumors on spermatogenesis and sperm DNA: a multicenter prospective study from the CECOS network. Fertil Steril 2013, 100:673-680.
125. Eisenberg M.L., Betts P., Herder D., Lamb D.J., Lipshultz L.I. Increased risk of cancer among azoospermic men. Fertil Steril 2013, 100:681-685.
126. Schüler S., Ponnath M., Engel J., Ortmann O. Ovarian epithelial tumors and reproductive factors: a systematic review. Arch Gynecol Obstet 2013, 2871187-2871204.
127. Anderson KN, Schwab RB, Martinez ME. Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat 2014 Jan 30. [Epub ahead of print].
128. Tea M.K., Weghofer A., Wagner K., Singer C.F. Association of BRCA1/2 mutations with FMR1 genotypes: effects on menarcheal and menopausal age. Maturitas. 2013, 75(2):148-151.
129. Gracia C.R., Sammel M.D., Freeman E., Prewitt M., Carlson C., Ray A., et al. Impact of cancer therapies on ovarian reserve. Fertil Steril 2012, 97:134-140.
130. Meistrich M.L. Effects of chemotherapy and radiotherapy on spermatogenesis in humans. Fertil Steril 2013, 100:1180-1186.
131. Roness H., Gavish Z., Cohen Y., Meirow D. Ovarian follicle burnout: a universal phenomenon?. Cell Cycle 2013, 12:3245-3246.
132. Hyman J.H., Tulandi T. Fertility preservation options after gonadotoxic chemotherapy. Clin Med Insights Reprod Health 2013, 7:61-69.
133. Anderson R.A., Rosendahl M., Kelsey T.W., Cameron D.A. Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer. Eur J Cancer 2013, 49(16):3404-3411.
134. Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update 2014, Jan 29 [Epub ahead of print].
135. Rustamov O., Smith A., Roberts S.A., Yates A.P., Fitzgerald C., Krishnan M., et al. Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability. Hum Reprod 2012, 27:3085-3091.
136. Azim H.A., Kroman N., Paesmans M., Gelber S., Rotmensz N., Ameye L., et al. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study. J Clin Oncol 2013, 31:73-79.
137. Stensheim H., Klungsøyr K., Skjaerven R., Grotmol T., Fosså S.D. Birth outcomes among offspring of adult cancer survivors: a population-based study. Int J Cancer 2013, 133:2696-2705.
138. Wang J.H., Muller C.H., Lin K. Optimizing fertility preservation for pre- and postpubertal males with cancer. Semin Reprod Med 2013, 31(4):274-285. [Epub 2013 Jun 17]. 10.1055/s-0033-1345275.
139. Berookhim BM, Mulhall JP. Outcomes of operative sperm retrieval strategies for fertility preservation among males scheduled to undergo cancer treatment. Fertil Steril 2014, Jan 11 [Epub ahead of print].
140. Signorello L.B., Mulvihill J.J., Green D.M., Munro H.M., Stovall M., Weathers R.E., et al. Congenital anomalies in the children of cancer survivors: a report from the childhood cancer survivor study. J Clin Oncol 2012, 30:239-245.
141. Winther J.F., Olsen J.H., Wu H., Shyr Y., Mulvihill J.J., Stovall M., et al. Genetic disease in the children of Danish survivors of childhood and adolescent cancer. J Clin Oncol 2012, 30:27-33.
142. Dekrem J., Van Calsteren K., Amant F. Effects of fetal exposure to maternal chemotherapy. Paediatr Drugs 2013, 15:329-334.
143. Pacey A.A., Merrick H., Arden-Close E., Morris K., Barton L.C., Crook A.J., et al. Monitoring fertility (semen analysis) by cancer survivors who banked sperm prior to cancer treatment. Hum Reprod 2012, 27(11):3132-3139.
144. Donnez J., Dolmans M.M., Pellicer A., Diaz-Garcia C., Sanchez Serrano M., Schmidt K.T., et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril 2013, 99:1503-1513.
145. Loren A.W., Mangu P.B., Beck L.N., Brennan L., Magdalinski A.J., Partridge A.H., et al. American Society of Clinical Oncology Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013, 31:2500-2510.
146. Prasath E.B., Chan M.L., Wong W.H., Lim C.J., Tharmalingam M.D., Hendricks M., et al. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. Hum Reprod 2014, 29:276-278.
147. Nogueira D., Sadeu J.C., Montagut J. In vitro oocyte maturation: current status. Semin Reprod Med 2012, 30(3):199-213.
148. Cakmak H., Rosen M.P. Ovarian stimulation in cancer patients. Fertil Steril 2013, 99:1476-1484.
149. Turan V., Bedoschi G., Moy F., Oktay K. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients. Fertil Steril 2013, 100:1681-1685.
150. van der Kaaij M.A., van Echten-Arends J., Simons A.H., Kluin-Nelemans H.C. Fertility preservation after chemotherapy for Hodgkin lymphoma. Hematol Oncol 2010, 28:168-179.
151. van der Kaaij M.A., Heutte N., Meijnders P., Abeilard-Lemoisson E., Spina M., Moser L.C., et al. Parenthood in survivors of Hodgkin lymphoma: an EORTC-GELA general population case-control study. J Clin Oncol 2012, 30:3854-3863.
152. Irtan S., Orbach D., Helfre S., Sarnacki S. Ovarian transposition in prepubescent and adolescent girls with cancer. Lancet Oncol 2013, 14:e601-608.
153. Pareja R., Rendón G.J., Sanz-Lomana C.M., Monzón O., Ramirez P.T. Surgical, oncological, and obstetrical outcomes after abdominal radical trachelectomy - a systematic literature review. Gynecol Oncol 2013, 131:77-82.
154. Zapardiel I, Diestro MD, Aletti G. Conservative treatment of early stage ovarian cancer: oncological and fertility outcomes. Eur J Surg Oncol 2013, Dec 13 [Epub ahead of print].
155. Hubbs J.L., Saig R.M., Abaid L.N., Bae-Jump V.L., Gehrig P.A. Systemic and local hormone therapy for endometrial hyperplasia and early adenocarcinoma. Obstet Gynecol 2013, 121:1172-1180.
156. Pacey AA, Eiser C. The importance of fertility preservation in cancer patients. Expert Rev Anticancer Ther 2014, Feb 9 [Epub ahead of print].
157. Yee S., Buckett W., Campbell S., Yanofsky R.A., Barr R.D. A national study of the provision of oncology sperm banking services among Canadian fertility clinics. Eur J Cancer Care (Engl) 2013, 22:440-449.
158. Armuand G.M., Rodriguez-Wallberg K.A., Wettergren L., Ahlgren J., Enblad G., Höglund M., et al. Sex differences in fertility-related information received by young adult cancer survivors. J Clin Oncol 2012, 30:2147-2153.
159. Schover L.R., Brey K., Lichtin A., Lipshultz L.I., Jeha S. Oncologists' attitudes and practices regarding banking sperm before cancer treatment. J Clin Oncol 2002, 20:1890-1897.
160. Ginsberg J.P., Ogle S.K., Tuchman L.K., Carlson C.A., Reilly M.M., Hobbie W.L., et al. Sperm banking for adolescent and young adult cancer patients: sperm quality, patient, and parent perspectives. Pediatr Blood Cancer 2008, 50:594-598.
161. van der Kaaij M.A.E., van Echten-Arends J., Heutte N., Meijnders P., Abeilard-Lemoisson E., Spina M., et al. Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study. Hum Reprod 2014, 29:525-533.
162. Chambers G.M., Hoang V.P., Sullivan E.A., et al. The impact of consumer affordability on access to assisted reproductive technologies and embryo transfer practices: an international analysis. Fertil Steril 2014, 101:191-198.
163. Chandra A., Stephen E.H. Infertility service use among U.S. women: 1995 and 2002. Fertil Steril 1995, 2010(93):725-736.
164. Letourneau J.M., Smith J.F., Ebbel E.E., et al. Racial, soioeconomic, and demographic disparities in access to fertility preservation in young women diagnosed with cancer. Cancer 2012, 118:4579-4588.
165. Goodman L.R., Balthazar U., Kim J., Mersereau J.E. Trends of socioeconomic disparities in referral patterns for fertility preservation consultation. Hum Reprod 2012, 27:2076-2081.
166. Kim J., Oktay K., Gracia C., Lee S., Morse C., Mersereau J.E. Which patients pursue fertility preservation treatments? A multicenter analysis of the predictors of fertility preservation in women with breast cancer. Fertil Steril 2012, 97:671-676.
167. Yee S., Buckett W., Campbell S., Yanofsky R., Barr R.D. A national study of the provision of oncofertility services to female patients in Canada. J Obstet Gynaecol Can 2012, 34:849-858.
168. Jenninga E., Hilders C.G., Louwe L.A., Peters A.A. Female fertility preservation: practical and ethical considerations of an underused procedure. Cancer J 2008, 14:333-339.
169. Kohler T.S., Kondapalli L.A., Shah A., et al. Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer. J Assist Reprod Genet 2011, 28:269-277.
170. Ramskold L.A., Posner M.P. Commercial surrogacy: how provisions of monetary remuneration and powers of international law can prevent exploitation of gestational surrogates. J Med Ethics 2013, 39:397-402.
171. Schover L.R., Rybicki L.A., Martin B.A., Bringelsen K.A. Having children after cancer. A pilot survey of survivors' attitudes and experiences. Cancer 1999, 86:697-709.
172. Schover L.R., Brey K., Lichtin A., Lipshultz L.I., Jeha S. Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. J Clin Oncol 2002, 20:1880-1889.
173. Partridge A.H., Gelber S., Peppercorn J., Sampson E., Knudsen K., Laufer M., et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 2004, 22:4174-4183.
174. Duffy C.M., Allen S.M., Clark M.A. Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol 2005, 23:766-773.
175. Burns K.C., Boudreau C., Panepinto J.A. Attitudes regarding fertility preservation in female adolescent cancer patients. J Pediatr Hematol Oncol 2006, 28:350-354.
176. Oosterhuis B.E., Goodwin T., Kiernan M., Hudson M.M., Dahl G.V. Concerns about infertility risks among pediatric oncology patients and their parents. Pediatr Blood Cancer 2008, 50:85-89.
177. Forman E.J., Anders C.K., Behera M.A. A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. Fertil Steril 2010, 94:1652-1656.
178. Quinn G.P., Vadaparampil S.T., Lee J.H., et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol 2009, 27:5952-5957.
179. Adams E., Hill E., Watson E. Fertility preservation in cancer survivors: a national survey of oncologists' current knowledge, practice and attitudes. Br J Cancer 2013, 108:1602-1615.
180. Gilbert E., Adams A., Mehanna H., Harrison B., Hartshorne G.M. Who should be offered sperm banking for fertility preservation? A survey of UK oncologists and haematologists. Ann Oncol 2011, 22:1209-1214.
181. Préaubert L., Poggi P., Pibarot M., Delotte J., Thibault E., Saias-Magnan J., et al. Fertility preservation among patients with cancer: report of a French regional practical experience. J Gynecol Obstet Biol Reprod (Paris) 2013, 42:246-251.
182. Letourneau J.M., Ebbel E.E., Katz P.P., Katz A., Ai W.Z., Chien A.J., et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer 2012, 118:1710-1717.
183. Saito K., Suzuki K., Iwasaki A., Yumura Y., Kubota Y. Sperm cryopreservation before cancer chemotherapy helps in the emotional battle against cancer. Cancer 2005, 104:521-524.
184. Canada A.L., Schover L.R. The psychosocial impact of interrupted childbearing in long-term female cancer survivors. Psychooncology 2012, 21:134-143.
185. Geue K, Richter D, Schmidt R, Sender A, Sidentopf F, Brähler E, Stöbel-Richter Y. The desire for children and fertility issues among young German cancer survivors. J Adolesc Health 2013, Dec 3 [Epub ahead of print].
186. Nagel K., Wizowski L., Duckworth J., Cassano J., Hahn S.A., Neal M. Using plain language skills to create an educational brochure about sperm banking for adolescent and young adult males with cancer. J Pediatr Oncol Nurs 2008, 25220-25226.
187. Huyghe E., Martinetti P., Sui D., Schover L.R. Banking on fatherhood: pilot studies of a computerized educational tool on sperm banking before cancer treatment. Psychooncology 2009, 18:1011-1014.
188. Garvelink M.M., ter Kuile M.M., Fischer M.J., Louwé L.A., Hilders C.G., Kroep J.R., et al. Development of a decision aid about fertility preservation for women with breast cancer in The Netherlands. J Psychosom Obstet Gynaecol 2013, 34:170-178.
189. Peate M., Meiser B., Cheah B.C., Saunders C., Butow P., Thewes B., et al. Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer. Br J Cancer 2012, 106:1053-1061.
190. Stacey D., Légaré F., Col N.F., Bennett C.L., Barry M.J., Eden K.B., et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2014, 1:CD001431.
191. Rosen A. Third-party reproduction and adoption in cancer patients. J Natl Cancer Inst Monogr 2005, 34:91-93.